FI883585A0 - Förfarande för faställande av närvaro av en ytantigen, en trombocytcell - Google Patents

Förfarande för faställande av närvaro av en ytantigen, en trombocytcell

Info

Publication number
FI883585A0
FI883585A0 FI883585A FI883585A FI883585A0 FI 883585 A0 FI883585 A0 FI 883585A0 FI 883585 A FI883585 A FI 883585A FI 883585 A FI883585 A FI 883585A FI 883585 A0 FI883585 A0 FI 883585A0
Authority
FI
Finland
Prior art keywords
surface antigen
determining
present
platelet cell
provides
Prior art date
Application number
FI883585A
Other languages
English (en)
Finnish (fi)
Other versions
FI95082C (sv
FI95082B (sv
FI883585A (sv
Inventor
Robert Mcmillan
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/936,125 external-priority patent/US4810632A/en
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of FI883585A0 publication Critical patent/FI883585A0/sv
Publication of FI883585A publication Critical patent/FI883585A/sv
Application granted granted Critical
Publication of FI95082B publication Critical patent/FI95082B/sv
Publication of FI95082C publication Critical patent/FI95082C/sv

Links

Classifications

    • G—PHYSICS
    • G02—OPTICS
    • G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/29—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the position or the direction of light beams, i.e. deflection
    • G02F1/31—Digital deflection, i.e. optical switching
    • G02F1/313—Digital deflection, i.e. optical switching in an optical waveguide structure
    • G02F1/3131—Digital deflection, i.e. optical switching in an optical waveguide structure in optical fibres
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • G—PHYSICS
    • G02—OPTICS
    • G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/35—Non-linear optics
    • G02F1/3515—All-optical modulation, gating, switching, e.g. control of a light beam by another light beam
    • G02F1/3517—All-optical modulation, gating, switching, e.g. control of a light beam by another light beam using an interferometer
    • G02F1/3519—All-optical modulation, gating, switching, e.g. control of a light beam by another light beam using an interferometer of Sagnac type, i.e. nonlinear optical loop mirror [NOLM]
    • G—PHYSICS
    • G02—OPTICS
    • G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F3/00—Optical logic elements; Optical bistable devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Nonlinear Science (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Optics & Photonics (AREA)
  • Zoology (AREA)
  • Power Engineering (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
FI883585A 1986-12-01 1988-07-29 Förfarande för faställande av närvaro av en ytantigen, en trombocytcell FI95082C (sv)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US93612586 1986-12-01
US06/936,125 US4810632A (en) 1986-12-01 1986-12-01 Cell surface antigen detection method
US07/124,905 US5176998A (en) 1986-12-01 1987-11-24 Cell surface antigen detection method
US12490587 1987-11-24
PCT/US1987/003129 WO1988004432A1 (en) 1986-12-01 1987-11-25 Cell surface antigen detection method
US8703129 1987-11-25

Publications (4)

Publication Number Publication Date
FI883585A0 true FI883585A0 (sv) 1988-07-29
FI883585A FI883585A (sv) 1988-07-29
FI95082B FI95082B (sv) 1995-08-31
FI95082C FI95082C (sv) 1995-12-11

Family

ID=26823073

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883585A FI95082C (sv) 1986-12-01 1988-07-29 Förfarande för faställande av närvaro av en ytantigen, en trombocytcell

Country Status (9)

Country Link
US (2) US5176998A (sv)
EP (1) EP0290595B1 (sv)
JP (1) JP2803824B2 (sv)
AT (1) ATE123341T1 (sv)
AU (1) AU594554B2 (sv)
DE (1) DE3751331T2 (sv)
DK (1) DK173838B1 (sv)
FI (1) FI95082C (sv)
NO (1) NO172910C (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5176998A (en) * 1986-12-01 1993-01-05 The Scripps Research Institute Cell surface antigen detection method
US5525461A (en) * 1991-11-01 1996-06-11 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using total leukocyte surface antigens
US5731425A (en) * 1994-10-28 1998-03-24 Eastman Kodak Company Polypeptide surface marker for cells
US6984526B2 (en) 1995-02-08 2006-01-10 University Of South Florida Spectrophotometric method for determining the viability of a sample containing platelets
US6330058B1 (en) 1999-04-14 2001-12-11 University Of South Florida Spectrophotometric method and apparatus for blood typing
US6379903B1 (en) 1999-10-08 2002-04-30 Sigma-Aldrich Co. Purification of recombinant proteins fused to multiple epitopes
US10338080B2 (en) 2008-12-01 2019-07-02 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for detection of complement fixing antibodies
WO2012070964A1 (ru) * 2010-11-22 2012-05-31 Farber Boris Slavinovich Модифицированные олигопептиды с противораковыми свойствами и способ их получения
CN105308457B (zh) 2013-03-14 2018-07-10 斯坦福大学托管董事会 检测供体特异性抗体的方法和用于实施所述方法的系统
US10527613B2 (en) 2015-11-10 2020-01-07 The Board Of Trustees Of The Leland Stanford Junior University Biomarker detection methods and systems and kits for practicing same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342566A (en) * 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
US4643971A (en) * 1983-03-11 1987-02-17 Sloan-Kettering Institute Monoclonal antibodies to human bladder and ureter cancers and method
EP0149168B1 (en) * 1983-12-19 1991-04-24 Daiichi Pure Chemicals Co. Ltd. Immunoassay
US4695538A (en) * 1984-06-01 1987-09-22 Sloan-Kettering Institute For Cancer Research Human monoclonal antibodies to cell surface antigens
JPS6181798A (ja) * 1984-07-23 1986-04-25 ベクトン・デイツキンソン・アンド・カンパニ− 細胞リセプタ−の回収
US4670394A (en) * 1984-11-16 1987-06-02 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Isolation and culture of adrenal medullary endothelial cells producing blood clotting factor VIII:C
US4810632A (en) * 1986-12-01 1989-03-07 Scripps Clinic And Research Foundation Cell surface antigen detection method
US5176998A (en) * 1986-12-01 1993-01-05 The Scripps Research Institute Cell surface antigen detection method

Also Published As

Publication number Publication date
EP0290595A1 (en) 1988-11-17
EP0290595B1 (en) 1995-05-31
FI95082C (sv) 1995-12-11
US5176998A (en) 1993-01-05
DK173838B1 (da) 2001-12-10
NO883367D0 (no) 1988-07-29
ATE123341T1 (de) 1995-06-15
DK426588A (da) 1988-07-29
NO172910C (no) 1993-09-22
DK426588D0 (da) 1988-07-29
FI95082B (sv) 1995-08-31
EP0290595A4 (en) 1990-12-19
NO883367L (no) 1988-07-29
AU594554B2 (en) 1990-03-08
NO172910B (no) 1993-06-14
AU1087688A (en) 1988-06-30
JPH01501571A (ja) 1989-06-01
FI883585A (sv) 1988-07-29
JP2803824B2 (ja) 1998-09-24
US5336597A (en) 1994-08-09
DE3751331D1 (de) 1995-07-06
DE3751331T2 (de) 1996-02-01

Similar Documents

Publication Publication Date Title
CA1313616C (en) Lateral flow, non-bibulous membrane protocols
NO890981L (no) Peptider og antistoffer som inhiberer blodplateadhesjon.
WO1985001354A1 (en) Detecting an immunological reaction with activated red blood cells (erythrocytes)
FI883585A0 (sv) Förfarande för faställande av närvaro av en ytantigen, en trombocytcell
ATE12010T1 (de) Verfahren zur bestimmung von antigen-antikoerper- reaktionen und reagens hierfuer.
DK196282A (da) Fremgangsmaade samt kit til bestemmelse af antistoffer mod oploeselige antigener
ES2176347T3 (es) Modulacion de la respuesta inmune.
IE862504L (en) Monoclonal antibody to leukocytes
NO331074B1 (no) Analysemetode for bestemmelse av holo-Transcobalamin II i en cellefri prove i et kroppsfluid.
ATE18920T1 (de) Radioimmunoassay fuer fibrinopeptid a.
ES8703021A1 (es) Procedimiento para detectar y determinar la concentracion de un analito presente en solucion acuosa
AU2353188A (en) A diagnostic agent and a method for the determination of apolipoprotein b
ES535553A0 (es) Un metodo para detectar un anticuerpo o un antigeno contenido en una muestra de fluido de origen biologico.
DE3674933D1 (de) Spezifisch hemmender speichel-alpha-amylase monoklonaler antikoerper und dessen verwendung zur bestimmung von pankreas-alpha-amylase.
DE3482924D1 (de) Reagenz zur verwendung im nachweis des antikoerpers gegen menschliche t-zellen-leukemievirusantigene.
Maidment Jr et al. Isoelectric focusing analysis of soluble immune complexes bound to Protein A-Sepharose
NO881998L (no) Fremgangsmaate til kvantitativ bestemmelse av serumproteiner i kroppsvaesker og middel til gjennomfoering av fremgangsmaaten.
DE3863270D1 (de) Immuntest.
IT9006603A1 (it) Test immunoenzimatico classe specifico per la ricerca e determinazione degli anticorpi anti-cardiolipina nel siero.
DK305084A (da) Partikel samt fremgangsmaade til paavisning af antigener og/eller antistoffer under anvendelse af partiklen

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: SCRIPPS CLINIC AND RESEARCH FOUNDATION